The sub-variant BA.2.75 redraws the efficacy picture of monoclonal antibodies. Compared to BA.2, BA.4 and BA.5, it…
monoclonal antibody
-
-
Business
The sales of the core product PD-1 toripalimab will gradually improve Junshi Bio responded to the 3.969 billion inquiry letter on fixed increase_Company_Pipeline_Project
by adminOriginal title: The sales of the core product PD-1 toripalimab will gradually improve Junshi Bio responded to…
-
(ANSA) – ROME – Monoclonal antibodies have been prescribed in Italy to 54,423 patients in just over…
-
(ANSA) – ROME, 04 MAR – The first long-acting monoclonal antibody designed to protect all newborns for…
-
Business
Innovent Asked to Supplement Additional Clinical Trials to Demonstrate the Applicability of Sintilimab in the U.S. Population and U.S. Medical Practice
by adminFebruary 11 at 10:30 a.m.,Innovent BioIt fell 3.66% to HK$32.9 per share, with a trading volume of…
-
(ANSA) – TRIESTE, 10 JAN – A biological drug, a monoclonal antibody capable of blocking fibrosis and…
-
“Today we are evaluating new monoclonals directed against protein S, the same used to induce antibody responses…
-
(ANSA) – ROME, 02 NOV – Monoclonal antibodies are effective in protecting elderly and diabetic macaque monkeys…
-
(ANSA) – ROME, SEPTEMBER 24 – The World Health Organization (WHO) has recommended a treatment based on…